Jorge Arca-Suárez

971 total citations
46 papers, 523 citations indexed

About

Jorge Arca-Suárez is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Jorge Arca-Suárez has authored 46 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Medicine, 26 papers in Pharmacology and 16 papers in Epidemiology. Recurrent topics in Jorge Arca-Suárez's work include Antibiotic Resistance in Bacteria (39 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers) and Pneumonia and Respiratory Infections (6 papers). Jorge Arca-Suárez is often cited by papers focused on Antibiotic Resistance in Bacteria (39 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers) and Pneumonia and Respiratory Infections (6 papers). Jorge Arca-Suárez collaborates with scholars based in Spain, France and United States. Jorge Arca-Suárez's co-authors include Germán Bou, Alejandro Beceiro, Juan Carlos Vázquez-Ucha, Fátima Galán‐Sánchez, Cristina Lasarte-Monterrubio, Manuel Rodríguez‐Iglesias, Antonio Oliver, Concepción González‐Bello, Marta Martínez-Guitián and Gabriel Cabot and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

Jorge Arca-Suárez

40 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorge Arca-Suárez Spain	13	454	230	124	119	112	46	523
Miki Takemura Japan	12	592 1.3×	432 1.9×	149 1.2×	130 1.1×	204 1.8×	34	707
Juan Carlos Vázquez-Ucha Spain	18	623 1.4×	299 1.3×	239 1.9×	125 1.1×	133 1.2×	43	771
Ester del Barrio-Tofiño Spain	7	523 1.2×	165 0.7×	270 2.2×	80 0.7×	134 1.2×	13	573
José Manuel Ortiz de la Rosa Switzerland	13	527 1.2×	193 0.8×	120 1.0×	77 0.6×	98 0.9×	29	582
Konstantina Dafopoulou Greece	9	396 0.9×	154 0.7×	86 0.7×	85 0.7×	71 0.6×	10	437
Anna Vickers United Kingdom	15	512 1.1×	328 1.4×	146 1.2×	199 1.7×	190 1.7×	23	699
Eva Gato Spain	11	427 0.9×	106 0.5×	184 1.5×	89 0.7×	74 0.7×	25	519
Panagiotis Poulikakos Greece	6	421 0.9×	199 0.9×	62 0.5×	155 1.3×	116 1.0×	8	529
Naoki Kohira Japan	8	681 1.5×	475 2.1×	199 1.6×	167 1.4×	188 1.7×	12	830
Eliana S. Armstrong United States	12	509 1.1×	292 1.3×	238 1.9×	160 1.3×	85 0.8×	17	722

Countries citing papers authored by Jorge Arca-Suárez

Since Specialization

Citations

This map shows the geographic impact of Jorge Arca-Suárez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Arca-Suárez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Arca-Suárez more than expected).

Fields of papers citing papers by Jorge Arca-Suárez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Arca-Suárez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Arca-Suárez. The network helps show where Jorge Arca-Suárez may publish in the future.

Co-authorship network of co-authors of Jorge Arca-Suárez

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Arca-Suárez. A scholar is included among the top collaborators of Jorge Arca-Suárez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Arca-Suárez. Jorge Arca-Suárez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodríguez-Pallares, Salud, et al.. (2025). Evolution of ceftazidime/avibactam resistance and plasmid dynamics in OXA-48-producing Klebsiella spp. during long-term patient colonization. European Journal of Clinical Microbiology & Infectious Diseases. 44(4). 807–817. 3 indexed citations

Fraile-Ribot, Pablo A., Esther Viedma, Ana Fernández-González, et al.. (2025). Rapid prediction of carbapenemases in Pseudomonas aeruginosa by imipenem/relebactam and MALDI-TOF MS. Journal of Clinical Microbiology. 63(5). e0110524–e0110524.

Guzmán-Puche, Julia, Marta Hernández-García, Julián Torre-Cisneros, et al.. (2025). Mechanisms of resistance to ceftazidime/avibactam in mutants derived in vitro from Klebsiella pneumoniae producing OXA-48-like enzymes. Journal of Antimicrobial Chemotherapy. 80(12). 3265–3272.

Gomis-Font, María A., Emilio Lence, Salud Rodríguez-Pallares, et al.. (2025). Functional and structural analyses of amino acid sequence variation in PDC β-lactamase reveal different mechanistic pathways toward cefiderocol resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 69(7). e0029225–e0029225. 3 indexed citations

Gomis-Font, María A., Salud Rodríguez-Pallares, Alejandro Beceiro, et al.. (2025). Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 69(12). e0104825–e0104825.

Arca-Suárez, Jorge, Emilio Lence, Andrea Muras, et al.. (2025). Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors. Antimicrobial Agents and Chemotherapy. 69(2). e0161424–e0161424. 7 indexed citations

López-Hernández, Inmaculada, Marı́a Pérez-Vázquez, Belén Aracil, et al.. (2024). Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions. International Journal of Antimicrobial Agents. 63(5). 107150–107150. 17 indexed citations

Rodríguez-Pallares, Salud, Emilio Lence, Ana Fernández-González, et al.. (2024). In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes. Antimicrobial Agents and Chemotherapy. 68(12). e0130724–e0130724. 1 indexed citations

Rodríguez-Pallares, Salud, María A. Gomis-Font, Pablo A. Fraile-Ribot, et al.. (2024). Impact of transferable β-lactamases and intrinsic AmpC amino acid substitutions on the activity of cefiderocol against wild-type and iron uptake-deficient mutants of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 79(11). 3023–3028. 7 indexed citations

10.

Rodríguez-Pallares, Salud, Eva Gato, Juan Carlos Vázquez-Ucha, et al.. (2024). Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime/avibactam resistance. Antimicrobial Agents and Chemotherapy. 68(12). e0112024–e0112024. 5 indexed citations

11.

Vázquez-Ucha, Juan Carlos, Marta Martínez-Guitián, Cristina Lasarte-Monterrubio, et al.. (2023). Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales. Antibiotics. 12(6). 999–999. 5 indexed citations

12.

Gato, Eva, Bruno K. Rodiño‐Janeiro, Javier Fernández, et al.. (2023). Direct Detection of Carbapenemase-Producing Klebsiella pneumoniae by MALDI-TOF Analysis of Full Spectra Applying Machine Learning. Journal of Clinical Microbiology. 61(6). e0175122–e0175122. 12 indexed citations

13.

Lasarte-Monterrubio, Cristina, Juan Carlos Vázquez-Ucha, Laura Álvarez-Fraga, et al.. (2023). Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1. Antimicrobial Agents and Chemotherapy. 67(5). e0150522–e0150522. 16 indexed citations

14.

Vázquez-Ucha, Juan Carlos, Cristina Lasarte-Monterrubio, Laura Álvarez-Fraga, et al.. (2023). Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain. International Journal of Antimicrobial Agents. 61(4). 106738–106738. 19 indexed citations

15.

Lasarte-Monterrubio, Cristina, Pablo A. Fraile-Ribot, Juan Carlos Vázquez-Ucha, et al.. (2022). Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 77(10). 2809–2815. 42 indexed citations

16.

Moscoso, Miriam, Juán A. Vallejo, María P. Cabral, et al.. (2022). A New Live Auxotrophic Vaccine Induces Cross-Protection against Klebsiella pneumoniae Infections in Mice. Vaccines. 10(6). 953–953. 8 indexed citations

17.

Vázquez-Ucha, Juan Carlos, Cristina Lasarte-Monterrubio, Emilio Lence, et al.. (2021). 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics. Journal of Medicinal Chemistry. 64(9). 6310–6328. 15 indexed citations

18.

Lasarte-Monterrubio, Cristina, Juan Carlos Vázquez-Ucha, Marı́a Maneiro, et al.. (2021). Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.. Antibiotics. 10(2). 210–210. 5 indexed citations

19.

Arca-Suárez, Jorge, Cristina Lasarte-Monterrubio, Gabriel Cabot, et al.. (2020). Molecular mechanisms driving thein vivodevelopment of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDRPseudomonas aeruginosainfections. Journal of Antimicrobial Chemotherapy. 76(1). 91–100. 49 indexed citations

20.

Arca-Suárez, Jorge, Juan Carlos Vázquez-Ucha, Pablo A. Fraile-Ribot, et al.. (2020). Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection. Journal of Antimicrobial Chemotherapy. 75(11). 3209–3217. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact